Replies to post #38792 on NanoViricides Inc. (NNVC)

[NNVClover]

I think you're missing the point - starting a phase 3, whether it's first patient in today or next month, is pretty quick and threatening any hope of success for NNVC. If everyone is innoculated, the need for a therapy is limited.

Also did you notice that dengue is a flavivirus? That means most hep c drugs will probably work as antivirals, as Roche is testing. There are other companies on the hunt for dengue drugs - AVII, etc. I think given NNVC's slim resources its unlikely much will come from this. Too many players in this field and we have no idea when an IND is coming.